SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. John M. de Castro who wrote (450)1/21/1999 5:11:00 PM
From: Mike McFarland  Read Replies (1) of 4474
 
Will be interesting to try and come up with
a comparison of the two vectors...from what
I can see from the Ariad work...and the
U of Pennsylvania patent, the hybrid adenovirus/
AAV vector and ARGENT seem to be a quite a bit
further along, but then does it really matter
whether or not it is primates or mice...much
was made of that on the Yahoo thread...but
maybe it was overstated?

Apparently there is a spirited debate going
on over on the Avigen yahoo thread about
Ariad...I've not yet checked it out, but might
be fun to read through all of that.

Whether or not I've guessed right having gone
with Ariad, time will tell. I sold my GMED a
month ago when it popped up briefly...took
some trading gains in Avigen and Cell Genesis,
Ariad is the only one that owes me, ha ha,
and I'm going to ride it for awhile. Might
even pick up another 1000 tommorrow...some
interesting volume spikes toward the end of
the day today, maybe MM's were accumulating
shares for a few large orders.

Say, Dr. de Castro--you still hangin' in there
with NTII?--still hardly any volume but at least
it ticked up a bit today...hope we hear something
on it one way or the other in the next month or two.

-Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext